|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | |
| C07K 16/00 | |||
| G01N 33/68 |
| (11) | Number of the document | 3250929 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16702782.0 |
| Date of filing the European patent application | 2016-01-29 | |
| (97) | Date of publication of the European application | 2017-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2016/050200 |
| Date | 2016-01-29 |
| (87) | Number | WO 2016/120633 |
| Date | 2016-08-04 |
| (30) | Number | Date | Country code |
| 201501597 | 2015-01-30 | GB |
| (72) |
RUDDOCK, Mark W., IE
REID, Cherith N., IE
WILLIAMSON, Kate E., IE
LAMONT, John, IE
FITZGERALD, Peter, IE
|
| (73) |
Randox Laboratories Ltd.,
Ardmore 55 Diamond Road Crumlin Co. Antrim BT29 4QY, Northern Ireland,
GB
|
| (54) | DIAGNOSIS OF RISK OF UROTHELIAL CANCER |
| DIAGNOSIS OF RISK OF UROTHELIAL CANCER |